EN中文

Presentations

Posters and talks from scientific meetings, newest first.

  • ESMO Asia Congress 2025. GTA182.

    First-in-Human Phase 1 Study of GTA182, a Novel MTA-Cooperative PRMT5 Inhibitor, in Patients with MTAP-Deleted Advanced Non-Small Cell Lung Cancer

    Late-breaking mini oral LBA14, presented by Shun Lu, MD, PhD

    Read the release

  • AACR Annual Meeting 2025. GTA182.

    GTA182: A potentially best-in-class, MTA-cooperative inhibitor for MTAP-deleted advanced solid tumors

    Abstract 4229

    View the poster

  • AACR Annual Meeting 2023. KIF18A.

    Targeting the mitotic kinesin, KIF18A, in chromosomally unstable cancers

    Abstract 4965

    View the poster

  • 34th EORTC-NCI-AACR Symposium, 2022. CDK7.

    Defining activity and patient selection of a novel CDK7 inhibitor, GTAEXS-617, through AI-supported primary cancer tissue profiling

    Abstract 124

    View the poster

  • AACR Annual Meeting 2022. CDK7.

    AI-driven discovery and profiling of GTAEXS-617, a selective and highly potent inhibitor of CDK7

    Abstract 3930

    View the poster

Earlier presentations are shown as given. Programs may have since changed name or owner.